Oya Cavagnaro News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oya cavagnaro. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oya Cavagnaro Today - Breaking & Trending Today

Ovid Therapeutics Appoints Dr. Joy A. Cavagnaro and Dr. Bruce A. Sullenger to its Scientific Advisory Board

New appointments strengthen neuroscience-focused Scientific Advisory Board NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced the appointment of Joy A. Cavagnaro, Ph.D., and Bruce A. Sullenger, Ph.D. to its Scientific Advisory Board. “Ovid is building the intellectual and scientific platform to tackle the big questions in neuroscience so as to develop new medicines. To that end, Ovid is deepening the expertise and strengths of our Scientific Advisory Board by the addition of key leaders in specific areas. Accordingly, I am delighted to welcome Dr. Cavagnaro and Dr. Sullenger to the SAB,” said Professor Robert S. Langer, Sc.D., Chair of Ovid’s Scientific Advisory Board. “Dr. Cavagnaro is renowned for her work in pre-clinical development and safety assessments for novel treatments, and D ....

Scientific Advisory Board , Ovid Therapeutics , Brucea Sullenger , Oya Cavagnaro , Iopharmaceutical Company , Translational Research , Pre Clinical Development , Neurological Diseases ,